GlassScriptPhysician profile
Derek L Norman
NPI 1376683573
$2,265.36
in general payments reported to CMS, 2019-2025
11 companies · $176 in 2025
The $176 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $298 · 2021: $286 · 2022: $678 · 2023: $539 · 2024: $290 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,004.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,004.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $782.24 | 2019-2023 | Repatha |
| Abbott Laboratories | $309.39 | 2021-2023 | Cardiomems |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $260.00 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $232.97 | 2022-2025 | Verquvo |
| Abiomed | $227.98 | 2022 | |
| Boston Scientific Corporation | $206.34 | 2022-2024 | Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $103.66 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $70.13 | 2019-2023 | Camzyos |
| Novartis Pharmaceuticals Corporation | $44.60 | 2021-2024 | |
| Asahi Intecc USA, INC. | $16.05 | 2024 | Peripheral Vascular |
| Atricure, INC. | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Norman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.